|
G |
Aldoc |
aldolase, fructose-bisphosphate C |
|
ISO |
mRNA, protein:decreased expression:cerebellum, Purkinje cell |
RGD |
PMID:17182680 |
RGD:2301132 |
NCBI chrNW_004936538:4,798,991...4,802,700
|
|
G |
Atf4 |
activating transcription factor 4 |
|
ISO |
protein:increased expression:cerebellum |
RGD |
PMID:16912310 |
RGD:32733622 |
NCBI chrNW_004936492:2,114,478...2,115,969
|
|
G |
Atf6 |
activating transcription factor 6 |
|
ISO |
protein:increased expression:cerebellum, hippocampus |
RGD |
PMID:16912310 |
RGD:32733622 |
NCBI chrNW_004937131:170,649...183,942
|
|
G |
Cd44 |
CD44 molecule (Indian blood group) |
|
ISO |
|
RGD |
PMID:16612977 |
RGD:2289373 |
NCBI chrNW_004936533:2,949,026...3,033,166
|
|
G |
Cx3cl1 |
C-X3-C motif chemokine ligand 1 |
|
ISO |
|
RGD |
PMID:12053272 |
RGD:4891998 |
NCBI chrNW_004936475:9,443,851...9,454,715
|
|
G |
Cx3cr1 |
C-X3-C motif chemokine receptor 1 |
|
ISO |
mRNA:increased expression:brain |
RGD |
PMID:12053272 |
RGD:4891998 |
NCBI chrNW_004936473:28,508,726...28,535,640
|
|
G |
Ddit3 |
DNA damage inducible transcript 3 |
|
ISO |
mRNA,protein:increased expression:cerebellum, hippocampus |
RGD |
PMID:16912310 |
RGD:32733622 |
NCBI chrNW_004936646:1,665,019...1,669,212
|
|
G |
Eif2a |
eukaryotic translation initiation factor 2A |
|
ISO |
protein:increased expression:cerebellum,hippocampus |
RGD |
PMID:16912310 |
RGD:32733622 |
NCBI chrNW_004936758:960,305...992,152
|
|
G |
Gja1 |
gap junction protein alpha 1 |
|
ISO |
|
RGD |
PMID:18538309 |
RGD:7364785 |
NCBI chrNW_004936658:3,920,043...3,932,987
|
|
G |
Gjb6 |
gap junction protein beta 6 |
|
ISO |
|
RGD |
PMID:18538309 |
RGD:7364785 |
NCBI chrNW_004936720:1,485,895...1,494,673
|
|
G |
Il16 |
interleukin 16 |
|
ISO |
protein:increased expression:brain |
RGD |
PMID:14698845 |
RGD:1354526 |
NCBI chrNW_004936483:19,417,580...19,512,654
|
|
G |
Mif |
macrophage migration inhibitory factor |
|
ISO |
protein:increased expression:astrocyte |
RGD |
PMID:11870869 |
RGD:1642006 |
NCBI chrNW_004936619:1,207,058...1,208,010
|
|
G |
Mt3 |
metallothionein 3 |
|
ISO |
|
RGD |
PMID:16612977 |
RGD:2289373 |
NCBI chrNW_004936475:8,864,512...8,866,516
|
|
G |
Parg |
poly(ADP-ribose) glycohydrolase |
|
ISO |
mRNA:decreased expression:hippocampus |
RGD |
PMID:18057239 |
RGD:2316738 |
NCBI chrNW_004936728:428,028...538,413
|
|
G |
Parp1 |
poly(ADP-ribose) polymerase 1 |
|
ISO |
mRNA,protein:increased expression,increased activity:neuron, glial cell: |
RGD |
PMID:18057239 |
RGD:2316738 |
NCBI chrNW_004936526:3,102,468...3,147,601
|
|
G |
Slc6a4 |
solute carrier family 6 member 4 |
|
ISO |
protein:increased expression:brain (rat) |
RGD |
PMID:12106671 |
RGD:38549588 |
NCBI chrNW_004936538:6,205,268...6,239,062
|
|
G |
Xbp1 |
X-box binding protein 1 |
|
ISO |
mRNA,protein:altered expression:cerebellum,hippocampus |
RGD |
PMID:16912310 |
RGD:32733622 |
NCBI chrNW_004936657:2,891,171...2,895,409
|
|
|
G |
Il3 |
interleukin 3 |
|
ISO |
protein: reduced expression: plasma |
RGD |
PMID:20957152 |
RGD:5686879 |
NCBI chrNW_004936647:3,102,922...3,104,758
|
|
|
G |
B2m |
beta-2-microglobulin |
|
ISO |
protein:increased expression:plasma |
RGD |
PMID:1402029 |
RGD:6482707 |
NCBI chrNW_004936471:7,646,504...7,655,656
|
|
G |
Cd46 |
CD46 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8402913 |
|
NCBI chrNW_004936557:5,136,784...5,175,543
|
|
G |
Muc1 |
mucin 1, cell surface associated |
severity |
ISO |
protein:increased expression:serum |
RGD |
PMID:11802251 |
RGD:5131281 |
NCBI chrNW_004936580:4,691,870...4,694,092
|
|
|
G |
Mavs |
mitochondrial antiviral signaling protein |
severity |
ISO |
|
RGD |
PMID:25953917 |
RGD:40903044 |
NCBI chrNW_004936485:14,842,778...14,859,163
|
|
|
G |
LOC101962495 |
transmembrane immune signaling adaptor TYROBP |
|
ISO |
ClinVar Annotator: match by term: Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1 |
OMIM ClinVar |
PMID:10888890 PMID:11109371 PMID:12370476 PMID:15883308 PMID:17125796 PMID:20500450 PMID:22082900 PMID:27658901 PMID:28492532 PMID:28620717 More...
|
|
NCBI chrNW_004936570:457,993...460,735
|
|
G |
Trem2 |
triggering receptor expressed on myeloid cells 2 |
|
ISO |
ClinVar Annotator: match by term: Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1 |
ClinVar |
PMID:12080485 PMID:12754369 PMID:12925681 PMID:15883308 PMID:18546367 PMID:21834902 PMID:23150934 PMID:23318515 PMID:23399524 PMID:24899047 PMID:24990881 PMID:25615530 PMID:25741868 PMID:27995897 PMID:28492532 PMID:28559417 PMID:28768830 PMID:29142083 PMID:29557178 More...
|
|
NCBI chrNW_004936476:18,659,725...18,665,406
|
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
|
ISO |
protein:increased expression:nasal mucus (human) |
RGD |
PMID:20182399 |
RGD:4891406 |
NCBI chrNW_004936490:253,279...259,947
|
|
G |
Cx3cl1 |
C-X3-C motif chemokine ligand 1 |
|
ISO |
|
RGD |
PMID:20053825 |
RGD:4891886 |
NCBI chrNW_004936475:9,443,851...9,454,715
|
|
G |
Cxcl9 |
C-X-C motif chemokine ligand 9 |
|
ISO |
protein:increased expression:nasal mucus |
RGD |
PMID:20182399 |
RGD:4891406 |
NCBI chrNW_004936676:33,580...40,323
|
|
|
G |
Il21 |
interleukin 21 |
|
ISO |
mRNA:increased expression:lung (mouse) |
RGD |
PMID:22238461 |
RGD:6892925 |
NCBI chrNW_004936662:1,689,879...1,696,883
|
|
G |
Il21r |
interleukin 21 receptor |
|
ISO |
|
RGD |
PMID:22238461 |
RGD:6892925 |
NCBI chrNW_004936501:11,100,170...11,112,112
|
|
G |
Pdcd1 |
programmed cell death 1 |
treatment |
ISO |
associated with reinfection |
RGD |
PMID:25339663 |
RGD:40822811 |
NCBI chrNW_004936745:152,571...163,712
|
|
|
G |
Camk2n1 |
calcium/calmodulin dependent protein kinase II inhibitor 1 |
|
ISO |
|
RGD |
PMID:17010311 |
RGD:18337278 |
NCBI chrNW_004936474:6,463,691...6,466,641
|
|
G |
Cd274 |
CD274 molecule |
|
ISO |
|
RGD |
PMID:18490751 |
RGD:41410795 |
NCBI chrNW_004936539:132,870...145,288
|
|
G |
Ncam1 |
neural cell adhesion molecule 1 |
|
ISO |
|
RGD |
PMID:9696812 |
RGD:40907065 |
NCBI chrNW_004936612:1,262,557...1,556,281
|
|
G |
Nefh |
neurofilament heavy chain |
|
ISO |
protein:increased expression:spinal cord: |
RGD |
PMID:29509660 |
RGD:27226884 |
NCBI chrNW_004936657:3,443,406...3,453,096
|
|
|
G |
Ace2 |
angiotensin converting enzyme 2 |
treatment severity |
ISO |
human protein in a mouse model |
RGD |
PMID:26813885 |
RGD:32716392 |
NCBI chrNW_004936470:4,964,526...5,011,808
|
|
G |
Aicda |
activation induced cytidine deaminase |
treatment |
ISO |
|
RGD |
PMID:27721128 |
RGD:127285642 |
NCBI chrNW_004936870:25,039...34,601
|
|
G |
Ccl1 |
C-C motif chemokine ligand 1 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:11134301 |
RGD:4891417 |
NCBI chrNW_004936538:781,687...784,199
|
|
G |
Ccl17 |
C-C motif chemokine ligand 17 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:17641031 |
RGD:4145495 |
NCBI chrNW_004936475:9,475,013...9,476,326
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
|
ISO |
protein:altered expression:lung, T cell (mouse) |
RGD |
PMID:19124761 |
RGD:4891880 |
NCBI chrNW_004936490:253,279...259,947
|
|
G |
Cd274 |
CD274 molecule |
severity |
ISO |
protein:increased expression: lung |
RGD |
PMID:25465101 |
RGD:11056952 |
NCBI chrNW_004936539:132,870...145,288
|
|
G |
Cd28 |
CD28 molecule |
|
ISO |
|
RGD |
PMID:18056387 |
RGD:5131621 |
NCBI chrNW_004936631:335,411...363,407
|
|
G |
Cftr |
CF transmembrane conductance regulator |
|
ISO |
DNA:mutation: : |
RGD |
PMID:20015999 |
RGD:4140389 |
NCBI chrNW_004936589:1,565,933...1,719,208
|
|
G |
Cx3cr1 |
C-X3-C motif chemokine receptor 1 |
severity |
ISO |
|
RGD |
PMID:12941892 PMID:16424189 |
RGD:4892016 RGD:4892018 |
NCBI chrNW_004936473:28,508,726...28,535,640
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
|
ISO |
|
RGD |
PMID:18624292 |
RGD:5135483 |
NCBI chrNW_004936676:60,869...63,028
|
|
G |
Cxcl9 |
C-X-C motif chemokine ligand 9 |
|
ISO |
protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:15916706 |
RGD:5135444 |
NCBI chrNW_004936676:33,580...40,323
|
|
G |
Cxcr3 |
C-X-C motif chemokine receptor 3 |
|
ISO |
|
RGD |
PMID:18624292 |
RGD:5135483 |
NCBI chrNW_004936762:66,636...69,694
|
|
G |
Dnase1 |
deoxyribonuclease 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:28780505 |
|
NCBI chrNW_004936694:704,948...715,846
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism protein:increased secretion:nasopharynx |
CTD RGD |
PMID:17425601 PMID:20209309 |
RGD:4140425 |
NCBI chrNW_004936659:616,570...627,172
|
|
G |
Ifng |
interferon gamma |
|
ISO |
associated with Otitis media;protein:increased expression:serum: CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:19352211 PMID:21937650 |
RGD:8142352 |
NCBI chrNW_004936545:6,139,130...6,144,543
|
|
G |
Il10 |
interleukin 10 |
severity |
ISO |
|
RGD |
PMID:20209309 |
RGD:4140425 |
NCBI chrNW_004936557:5,834,874...5,838,502
|
|
G |
Il13 |
interleukin 13 |
|
ISO |
|
RGD |
PMID:18250447 |
RGD:4145641 |
NCBI chrNW_004936647:2,529,933...2,532,503
|
|
G |
Il17a |
interleukin 17A |
severity |
ISO |
protein:increased expression:plasma |
RGD |
PMID:19738511 |
RGD:4889103 |
NCBI chrNW_004936476:8,621,860...8,625,008
|
|
G |
Il18 |
interleukin 18 |
|
ISO |
DNA:polymorphism:intron:rs360721 (human) |
RGD |
PMID:18043444 PMID:20130064 |
RGD:4889550 RGD:4889584 |
NCBI chrNW_004936612:2,306,963...2,325,086
|
|
G |
Il1rl1 |
interleukin 1 receptor like 1 |
|
ISO |
|
RGD |
PMID:11283151 |
RGD:5144238 |
NCBI chrNW_004936713:1,020,969...1,035,012
|
|
G |
Il27 |
interleukin 27 |
ameliorates |
ISO |
|
RGD |
PMID:22301139 |
RGD:126790525 |
NCBI chrNW_004936501:11,972,715...11,978,152
|
|
G |
Il2ra |
interleukin 2 receptor subunit alpha |
|
ISO |
|
RGD |
PMID:20639494 |
RGD:5147443 |
NCBI chrNW_004936484:8,514,333...8,555,392
|
|
G |
Il33 |
interleukin 33 |
|
ISO |
|
RGD |
PMID:26044350 PMID:28771101 |
RGD:11342984 RGD:39939029 |
NCBI chrNW_004936539:763,755...791,461
|
|
G |
Il5 |
interleukin 5 |
severity |
ISO |
|
RGD |
PMID:25410867 |
RGD:11354937 |
NCBI chrNW_004936647:2,647,982...2,651,477
|
|
G |
Il5ra |
interleukin 5 receptor subunit alpha |
|
ISO |
protein:decreased expression:blood, eosinophil |
RGD |
PMID:16734609 |
RGD:5128618 |
NCBI chrNW_004936577:2,776,608...2,797,303
|
|
G |
Il6 |
interleukin 6 |
severity |
ISO |
protein:increased expression:nasal mucus associated with Otitis media;protein:increased expression:serum: |
RGD |
PMID:19352211 PMID:20622030 |
RGD:4143259 RGD:8142352 |
NCBI chrNW_004936549:7,015,595...7,016,246
|
|
G |
Il9 |
interleukin 9 |
susceptibility |
ISO |
DNA:SNPs: :rs2069885, rs1799962 (human) |
RGD |
PMID:19915054 PMID:20503287 |
RGD:5128684 RGD:5128685 |
NCBI chrNW_004936597:2,983,953...2,986,975
|
|
G |
Irf1 |
interferon regulatory factor 1 |
|
ISO |
protein:increased expression:dorsal root ganglion |
RGD |
PMID:20045913 |
RGD:5128775 |
NCBI chrNW_004936647:2,686,247...2,693,633
|
|
G |
LOC101958191 |
thymic stromal lymphopoietin |
sexual_dimorphism |
ISO |
mRNA:increased expression:lung (mouse) protein:increased expression:nasal mucus (human) |
RGD |
PMID:27156176 PMID:28471975 PMID:31076663 |
RGD:38549376 RGD:38596342 RGD:38596346 |
NCBI chrNW_004936531:5,495,872...5,500,462
|
|
G |
LOC101964975 |
interleukin-8 |
|
ISO |
protein:increased expression:nasopharynx(human) |
RGD |
PMID:29325581 |
RGD:150521551 |
NCBI chrNW_004936598:1,779,471...1,781,353
|
|
G |
LOC101968920 |
eotaxin |
|
ISO |
|
RGD |
PMID:10955955 |
RGD:4145447 |
NCBI chrNW_004936538:835,436...848,907
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
|
ISO |
mRNA, protein:increased expression, increased activity:bronchoalveolar lavage fluid |
RGD |
PMID:17254480 |
RGD:5130726 |
NCBI chrNW_004936475:7,801,356...7,825,831
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
ISO |
mRNA, protein:increased expression, increased activity:bronchoalveolar lavage fluid |
RGD |
PMID:17254480 |
RGD:5130726 |
NCBI chrNW_004936514:7,038,240...7,045,873
|
|
G |
Muc5ac |
mucin 5AC, oligomeric mucus/gel-forming |
|
ISO |
associated with Respiratory Hypersensitivity; protein:increased expression:lung |
RGD |
PMID:15130904 |
RGD:5131205 |
NCBI chrNW_004936816:129,926...159,396
|
|
G |
Ngf |
nerve growth factor |
|
ISO |
|
RGD |
PMID:19824047 |
RGD:4891065 |
NCBI chrNW_004936627:635,784...641,290
|
|
G |
Ngfr |
nerve growth factor receptor |
|
ISO |
|
RGD |
PMID:19824047 |
RGD:4891065 |
NCBI chrNW_004936490:12,038,500...12,057,257
|
|
G |
Pdcd1 |
programmed cell death 1 |
|
ISO |
protein:increased expression:CD4 Tcell, CD8 Tcell from lung: protein:increased expression: CD8 Tcell from nasal wash: |
RGD |
PMID:25465101 |
RGD:11056952 |
NCBI chrNW_004936745:152,571...163,712
|
|
G |
Pde12 |
phosphodiesterase 12 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26055709 |
|
NCBI chrNW_004936473:7,894,026...7,897,844
|
|
G |
Ripk3 |
receptor interacting serine/threonine kinase 3 |
ameliorates |
ISO |
|
RGD |
PMID:33303545 |
RGD:127229923 |
NCBI chrNW_004936722:209,019...212,817
|
|
G |
Rsad2 |
radical S-adenosyl methionine domain containing 2 |
treatment |
ISO |
|
RGD |
PMID:23018837 |
RGD:11554170 |
NCBI chrNW_004936532:3,921,824...3,936,027
|
|
G |
Sarm1 |
sterile alpha and TIR motif containing 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24478430 |
|
NCBI chrNW_004936538:4,526,713...4,546,861
|
|
G |
Scgb1a1 |
secretoglobin family 1A member 1 |
|
ISO |
|
RGD |
PMID:12847279 |
RGD:5144208 |
NCBI chrNW_004936581:798,738...801,614
|
|
G |
Sftpb |
surfactant protein B |
severity |
ISO |
DNA:SNPs:promoter, cds, intron:-32G>T (rs2077079), p.T131I (rs1130866), 5781A>C (rs2040349) (human) protein:decreased expression:lung |
RGD |
PMID:10194154 PMID:17498296 |
RGD:4143382 RGD:4143439 |
NCBI chrNW_004936712:1,614,979...1,621,207
|
|
G |
Sftpc |
surfactant protein C |
|
ISO |
DNA:polymorphism: :138A>C, 186A>G (human) |
RGD |
PMID:17121584 PMID:19304906 |
RGD:4144065 RGD:4144116 |
NCBI chrNW_004936555:5,966,610...5,982,083
|
|
G |
Sftpd |
surfactant protein D |
susceptibility |
ISO |
DNA:polymorphisms: :p.M11T, p.A160T (human protein:decreased expression:lung |
RGD |
PMID:10194154 PMID:19287351 |
RGD:4143439 RGD:4143495 |
NCBI chrNW_004936716:60,754...73,010
|
|
G |
Tac1 |
tachykinin precursor 1 |
|
ISO |
mRNA,protein:increased expression:lung |
RGD |
PMID:10516226 |
RGD:5147822 |
NCBI chrNW_004936585:2,932,783...2,941,141
|
|
G |
Tacr1 |
tachykinin receptor 1 |
treatment |
ISO |
|
RGD |
PMID:10516226 |
RGD:5147822 |
NCBI chrNW_004936556:1,266,621...1,421,271
|
|
G |
Ticam1 |
toll like receptor adaptor molecule 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24478430 |
|
NCBI chrNW_004936588:2,818,909...2,827,797
|
|
G |
Tlr2 |
toll like receptor 2 |
|
ISO |
|
RGD |
PMID:19019963 |
RGD:4889534 |
NCBI chrNW_004936576:522,234...531,660
|
|
G |
Tlr3 |
toll like receptor 3 |
|
ISO |
|
RGD |
PMID:16424225 |
RGD:5129224 |
NCBI chrNW_004936554:3,370,766...3,388,125
|
|
G |
Tlr4 |
toll like receptor 4 |
susceptibility no_association |
ISO |
DNA:polymorphisms:cds:p.D259G, T359I (human) DNA:SNPs:cds:p.D299G, T399I (human) DNA:SNP:cds:p.D299G (human) |
RGD |
PMID:17264400 PMID:17449325 PMID:17709532 PMID:19019963 |
RGD:4144161 RGD:4144164 RGD:4144167 RGD:4889534 |
NCBI chrNW_004936487:6,519,140...6,532,018
|
|
G |
Tlr6 |
toll like receptor 6 |
|
ISO |
|
RGD |
PMID:19019963 |
RGD:4889534 |
NCBI chrNW_004936482:6,607,723...6,610,161
|
|
G |
Tlr7 |
toll like receptor 7 |
|
ISO |
associated with Bronchiolitis; mRNA:increased expression:nasopharynx (human) |
RGD |
PMID:19386802 |
RGD:5129471 |
NCBI chrNW_004936470:2,593,544...2,610,972
|
|
G |
Tlr8 |
toll like receptor 8 |
|
ISO |
associated with Bronchiolitis; mRNA:increased expression:nasopharynx (human) |
RGD |
PMID:19386802 |
RGD:5129471 |
NCBI chrNW_004936470:2,638,020...2,642,201
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
protein:increased expression:Bronchoalveolar lavage fluid |
RGD |
PMID:15791294 |
RGD:4145715 |
NCBI chrNW_004936727:1,936,066...1,937,766
|
|
|
G |
Ccl28 |
C-C motif chemokine ligand 28 |
|
ISO |
mRNA:increased expression:lung (mouse) |
RGD |
PMID:17954569 |
RGD:4892194 |
NCBI chrNW_004936480:18,819,012...18,824,981
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
ISO |
mRNA, protein:increased expression, increased activity:lung |
RGD |
PMID:16816895 |
RGD:5130923 |
NCBI chrNW_004936514:7,038,240...7,045,873
|
|
G |
Ppia |
peptidylprolyl isomerase A |
exacerbates |
ISO |
|
RGD |
PMID:28594325 |
RGD:150429629 |
NCBI chrNW_004936478:19,669,727...19,673,355
|
|
|
G |
Atm |
ATM serine/threonine kinase |
ameliorates |
ISO |
|
RGD |
PMID:25692705 |
RGD:126790565 |
NCBI chrNW_004936551:359,134...534,672
|
|
|
G |
LOC101968921 |
angiotensin-converting enzyme |
|
ISO |
DNA:insertion/deletion: |
RGD |
PMID:16741935 |
RGD:40400901 |
NCBI chrNW_004936541:4,157,847...4,178,156
|
|
|
G |
Ehmt2 |
euchromatic histone lysine methyltransferase 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:26418342 |
|
NCBI chrNW_004936727:1,648,451...1,663,294
|
|
G |
Ripk3 |
receptor interacting serine/threonine kinase 3 |
ameliorates |
ISO |
|
RGD |
PMID:25326752 |
RGD:127229916 |
NCBI chrNW_004936722:209,019...212,817
|
|
G |
Stat2 |
signal transducer and activator of transcription 2 |
exacerbates |
ISO |
|
RGD |
PMID:32759968 |
RGD:41789624 |
NCBI chrNW_004936646:747,178...763,449
|
|